🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. Oxycodone (OxyNorm®) Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pain

    phase 1 small molecule completed

    1 trial

  2. Oxycodone Tamper Resistant

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Pain

    phase 1 small molecule completed

    3 trials

  3. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxytocin Effect on Memory Performance During Phase 1

    phase 1 small molecule completed

    1 trial

  4. Oxytocin lower does (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  5. Oxytocin lower dose (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healhty

    phase 1 small molecule active

    1 trial

  6. Oxytocin nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

  7. PEGylated recombinant human interferon alpha-2b injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    phase 1 small molecule active

    1 trial

  8. Pyrotinib low dose group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 1 small molecule active

    1 trial

  9. QLS32015

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma (RRMM)

    phase 1 mab active

    1 trial

  10. QN-023a

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML, Adult

    phase 1 small molecule terminated

    1 trial

  11. QT-019C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SLE - Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  12. Qing'E pill

    Shanghai University of Traditional Chinese Medicine

    Menopause

    phase 1 small molecule completed

    1 trial

  13. RD13-02

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Severe Aplastic Anemia

    phase 1 mab active

    1 trial

  14. RJMty19 (CD19-CAR-DNT cells)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Non-Hodgkin's Lymphoma

    phase 1 mab active

    1 trial

  15. Rapamycin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Graves Ophthalmopathy

    phase 1 small molecule active

    1 trial

  16. Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo

    Shanghai University of Traditional Chinese Medicine

    Healthy

    phase 1 small molecule completed

    1 trial

  17. Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 1 mab completed

    1 trial

  18. Recombinant oncolytic herpes simplex virus type Ⅰ (R130)

    Shanghai University of Traditional Chinese Medicine

    Osteosarcoma

    phase 1 small molecule active

    1 trial

  19. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Carcinoma

    phase 1 small molecule completed

    1 trial

  20. SCT-001 CAR-T cells

    Shanghai University of Traditional Chinese Medicine

    Ovarian Cancer

    phase 1 mab active

    1 trial

  21. SIBP-A13 formulation for injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  22. SYHA1813 oral solution (2.0g:25mg)

    Shanghai University of Traditional Chinese Medicine

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  23. SYS6055

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory B-Cell Malignancies

    phase 1 small molecule active

    1 trial

  24. Sanchi-Tongshu Capsule (Enteric coated pellets)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources